首页> 外文OA文献 >Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas

【2h】

Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas

机译：在伊马替尼作为佐剂治疗的局部胃肠道间质瘤中，确定第一种酪氨酸激酶抑制剂最终失效的时间：欧洲癌症软组织和骨肉瘤组的研究和治疗组织与澳大利亚胃肠道试验组合作进行了组间随机试验，UNICANCER，法国肉瘤小组，意大利肉瘤小组和西班牙肉瘤研究小组

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Casali, Paolo G; Le Cesne, Axel; Velasco, Andres Poveda; Kotasek, Dusan; Rutkowski, Piotr; Hohenberger, Peter; Fumagalli, Elena; Judson, Ian R.; Italiano, Antoine; Gelderblom, Hans; Adenis, Antoine; Hartmann, Jörg T.; Duffaud, Florence; Goldstein, David; Broto, Javier M.; Gronchi, Alessandro; Dei Tos, Angelo; Marréaud, Sandrine; Van Der Graaf, Winette T.A.; Zalcberg, John R.; Litière, Saskia; Blay, Jean-Yves;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
专利

1. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas [J] . Paolo G. Casali Journal of Clinical Oncology . 2015,第36期

机译：伊马替尼作为佐剂治疗的局部胃肠道间质瘤中第一种酪氨酸激酶抑制剂确定性失败的时间：一个研究和治疗癌症软组织和骨肉瘤组的欧洲组织与澳大利亚胃肠道试验组合作进行的组间随机试验，UNICANCER，法国肉瘤小组，意大利肉瘤小组和西班牙肉瘤研究小组
2. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels [J] . Casali Paolo G., Zalcberg John, Le Cesne Axel, Journal of Clinical Oncology . 2017,第15期

机译：患有不可切除或转移性胃肠基质肿瘤的患者的十年进展和整体生存：对欧洲癌症，意大利肉瘤组和澳大利亚胃肠试验组Intergrous阶段III阶段的癌症阶段III阶段III族随机试验的长期分析在两种剂量水平
3. Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). [J] . Gronchi A, Judson I, Nishida T European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2009,第7期

机译：伊马替尼对GIST的辅助治疗：坚实的地面还是流沙？代表EORTC软组织和骨肉瘤小组，意大利肉瘤小组，NCRI肉瘤临床研究小组（英国），日本GIST研究小组，法国肉瘤小组和西班牙肉瘤小组（GEIS）发表评论。
4. Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study [O] . N Penel, M V Glabbeke, S Mathoulin-Pelissier, 2011

机译：表现状态是晚期软组织肉瘤患者早期死亡的最有力危险因素欧洲癌症研究和治疗组织–软组织和骨肉瘤小组（STBSG）和法国肉瘤小组（FSG）的研究
5. Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas [O] . Casali, Paolo G, Le Cesne, Axel, Velasco, Andres Poveda, 2015

机译：在伊马替尼作为佐剂治疗的局部胃肠道间质瘤中，确定第一种酪氨酸激酶抑制剂最终失效的时间：欧洲癌症软组织和骨肉瘤组的研究和治疗组织与澳大利亚胃肠道试验组合作进行了组间随机试验，UNICANCER，法国肉瘤小组，意大利肉瘤小组和西班牙肉瘤研究小组

著录项

相似文献

相关主题

期刊订阅